42 generic drugs referencing Bukwang Pharm’s ‘Dexid Tab’ were bioequivalently tested this year
This year, 291 pharmaceutical products have been bioequivalently tested. The number was reportedly increased by 46% compared to the same time period.
This means Korean pharmaceutical companies have been very active in developing generic drugs as many original drugs are expiring with patent and P...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
